Ceribell, Inc. is a commercial-stage medical technology company. It is focused on transforming the diagnosis and management of patients with serious neurological conditions. It has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining proprietary, highly portable and rapidly deployable hardware with sophisticated artificial intelligence (AI)-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions. Point-of-Care EEG enables early detection and management of suspected seizure patients, promoting precise patient care and hospital-wide efficiencies. Its Clarity AI algorithm interprets EEG in real-time, provides bedside alerts and continuous monitoring for status epilepticus. The Ceribell EEG Portal makes it easy to remotely review EEG in real-time with pre-annotated EEG insights.
종목 코드 CBLL
회사 이름Ceribell Inc
상장일Oct 11, 2024
CEOMs. Xingjuan (Jane) Chao, Ph.D.
직원 수281
유형Ordinary Share
회계 연도 종료Oct 11
주소360 N. Pastoria Avenue
도시SUNNYVALE
증권 거래소NASDAQ Global Select Consolidated
국가United States of America
우편 번호94085
전화18004360826
웹사이트https://ceribell.com/
종목 코드 CBLL
상장일Oct 11, 2024
CEOMs. Xingjuan (Jane) Chao, Ph.D.
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.

데이터 없음